Laboratory of Lymphocyte Signaling and Oncoproteome

Legal notice

Legal Disclosure

Information in accordance with Section 5 TMG 

Kerpener Str. 62
Haus 15, Raum. 1.010
50937 Köln

Represented by

Marco Herling

Contact Information

Telephone: +49 (0) 221 478 5969
E-Mail: petra.mayer@uk-koeln.de
Internet address: herlinglab.com

Verantwortlich für den Inhalt dieser Seiten:

Marco Herling
Kerpener Str. 62, Haus 15, R.1.010
Telefon: +49 (0) 221 478 5969
E-Mail: petra.mayer@uk-koeln.de
Internet: herlinglab.com

News

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

November 21, 2019

New meta-analysis on JAK/STAT genomic alterations in T-PLL published in Cancers.

We congratulate Dr. Sebastian Oberbeck on his PhD defence!

We congratulate Dr. Sebastian Oberbeck on his PhD defence!

October 30, 2019

On October 30th, Sebastian Oberbeck successfully defended his PhD. Congratulations!